By using this site, you agree to the Privacy Policy and Terms & Conditions.
Accept
Okay.ngOkay.ngOkay.ng
Font ResizerAa
  • News
    • Politics
  • Entertainment
  • Business & Economy
  • Sport
  • Tech
Reading: Pyramax as candidate for COVID-19?
Share
Font ResizerAa
Okay.ngOkay.ng
  • News
  • Entertainment
  • Business & Economy
  • Sport
  • Tech
Search
  • News
    • Politics
  • Entertainment
  • Business & Economy
  • Sport
  • Tech
Follow US
  • About Okay.ng
  • Advertising on Okay.ng
  • Contact Okay.ng
  • Careers
  • Meet the Team behind Okay.ng
  • Ownership and Funding of Okay.ng
  • Editorial Principles at Okay.ng
© OKN MEDIA PUBLISHING 2022 - All rights reserved
Featured

Pyramax as candidate for COVID-19?

Okay.ng
By Okay.ng
Published: June 3, 2020
Share
2 Min Read
SHARE

On 31st December 2019, COVID 19 the novel coronavirus detected in Wuhan, China was reported to the World Health Organization (WHO) Country Office in China. On 30th January 2020, it was declared a Public Health Emergency of International Concern and by March 11th COVID-19 was declared a pandemic, pointing to the over 118,000 cases of the coronavirus illness in over 110 countries and territories around the world.

Since then it is on record that no drug or vaccine has been officially approved for the treatment of COVID-19.

However, several candidate drug molecules, including the repurposed are emerging through anecdotal reports as providing benefits to COVID-19 patients. Drug molecules developed for treatment of ailments like Malaria and Ebola in different parts of the world.

Pyramax is a WHO prequalified artemisinin-based combination therapy for the treatment of malaria contains the active substances Pyronaridine tetraphosphate and Artesunate is presently undergoing phase 2 clinical trials for the treatment of COVID-19. Pyramax a drug of choice in the treatment of malaria is registered and was launched in Nigeria in 2018 being available in Hospitals and Pharmacies in Nigeria.

- Advertisement -

Pyramax has officially been approved for clinical trials in South Korea to compare and evaluate efficacy and safety in treating patients infected with the novel coronavirus after its manufacturer, Shin Poong Pharmaceuticals received approval of the Ministry of Food and Drug Safety South Korea to conduct clinical trials on Pyramax .

While following up on the potential of Pyramax during the clinical studies it is good news that this medicine can be accessed in the Nigeria pharmaceutical space.

Stay Updated on the Go with Our Latest News—Join Our WhatsApp Channel Now!
TAGGED:COVID19Pyramax
Share This Article
Facebook Whatsapp Whatsapp Telegram Email Copy Link Print
ByOkay.ng
Follow:
Okay.ng launched under OKN MEDIA PUBLISHING (RC Number: 2993580) in the year 2012 is an independent digital news platform with thousands of page views and unique visitors every month
Previous Article Abdullahi Dikko Inde Court dismisses N1.1bn fraud charges against Ex-Customs CG, Dikko Inde
Next Article June 3rd: Buhari presides virtual FEC meeting [Photos]

Connect with Okay on Social

FacebookLike
XFollow
InstagramFollow
TelegramFollow

Dollar/Naira Rates

Dollar to Naira Exchange Rate

Okay.ng Logo
Buy Rate ₦1,605.00
Sell Rate ₦1,620.00

Last updated: 5 days ago (June 3, 2025 2:33 pm)

Displayed rates are for informational purposes only and are subject to change.

USD/NGN Converter

- Advertisement -
- Advertisement -
Ad imageAd image
- Advertisement -
Ad imageAd image

Recent Posts

Pastor Adeboye
Pastor Adeboye Shares Divine Directive: Leaving RCCG Could Lead to Tragic Loss
News
Anglican Bishop of Lafia Calls on President Tinubu to Address Root Causes of Nigeria’s Insecurity and Economic Woes
News
Egbe Bobakeye Okunrin Akile Ijebu Refutes False Claims About Queen Elizabeth II’s 1956 Visit
News
NRC Managing Director Warns Against Railway Vandalism: “We Don’t Have Scraps, We Have National Assets”
News
Tragic Head-On Collision in Jigawa Claims Nine Lives, Dozens Injured
News
- Advertisement -
Ad imageAd image

You May Also Like

Sport

Victor Osimhen Returns to Nigeria as Al Hilal Transfer Hangs in Balance Ahead of FIFA Club World Cup

Oluwadara Akingbohungbe
Oluwadara Akingbohungbe
June 7, 2025
News

Tinubu Urged by PDP to Cut Fuel and Electricity Costs Amid Eid-el-Kabir Festivities

Oluwadara Akingbohungbe
Oluwadara Akingbohungbe
June 7, 2025
Mike Ejeagha
News

Mike Ejeagha, Nigerian Highlife Maestro, Dies at 95

Muhammad A. Aliyu
Muhammad A. Aliyu
June 7, 2025
Okay.ngOkay.ng
Follow US
© OKN MEDIA PUBLISHING 2025 - All rights reserved
  • About Okay.ng
  • Advertising on Okay.ng
  • Contact Okay.ng
  • Careers
  • Meet the Team behind Okay.ng
  • Ownership and Funding of Okay.ng
  • Editorial Principles at Okay.ng
adbanner
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?